Unlike the other ADAMTS genes, the survival analysis indicated that the up-regulation of ADAMTS1, ADAMTS3, or ADAMTS6 increased risk of death in GC patients (P<0.05) (Figure 7A–H). Here, ADAMTS6 is linked to gastric cancer.